Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 121 Pages
Report ld: 4212406
Request Sample
Customized Report
Polycaprolactam Market Size(US$)

CAGR 2025-2031
6.3%
Market Size,2031
USD 12,230
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
North American market for Polycaprolactam was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Polycaprolactam was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Polycaprolactam was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Polycaprolactam include BASF SE, Honeywell, Royal DSM N.V, Lanxess, Clariant Corporation, Unitika, DOMO Chemicals, Firestone Textiles Company, Grupa Azoty, LIBOLON, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Polycaprolactam, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polycaprolactam by region & country, by Type, and by Application.
The Polycaprolactam market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycaprolactam.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polycaprolactam manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polycaprolactam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polycaprolactam in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polycaprolactam Product Introduction
1.2 Global Polycaprolactam Market Size Forecast
1.2.1 Global Polycaprolactam Sales Value (2020-2031)
1.2.2 Global Polycaprolactam Sales Volume (2020-2031)
1.2.3 Global Polycaprolactam Sales Price (2020-2031)
1.3 Polycaprolactam Market Trends & Drivers
1.3.1 Polycaprolactam Industry Trends
1.3.2 Polycaprolactam Market Drivers & Opportunity
1.3.3 Polycaprolactam Market Challenges
1.3.4 Polycaprolactam Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polycaprolactam Players Revenue Ranking (2024)
2.2 Global Polycaprolactam Revenue by Company (2020-2025)
2.3 Global Polycaprolactam Players Sales Volume Ranking (2024)
2.4 Global Polycaprolactam Sales Volume by Company Players (2020-2025)
2.5 Global Polycaprolactam Average Price by Company (2020-2025)
2.6 Key Manufacturers Polycaprolactam Manufacturing Base and Headquarters
2.7 Key Manufacturers Polycaprolactam Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Polycaprolactam
2.9 Polycaprolactam Market Competitive Analysis
2.9.1 Polycaprolactam Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Polycaprolactam Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycaprolactam as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Standard Type
3.1.2 Reinforced Type
3.2 Global Polycaprolactam Sales Value by Type
3.2.1 Global Polycaprolactam Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Polycaprolactam Sales Value, by Type (2020-2031)
3.2.3 Global Polycaprolactam Sales Value, by Type (%) (2020-2031)
3.3 Global Polycaprolactam Sales Volume by Type
3.3.1 Global Polycaprolactam Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Polycaprolactam Sales Volume, by Type (2020-2031)
3.3.3 Global Polycaprolactam Sales Volume, by Type (%) (2020-2031)
3.4 Global Polycaprolactam Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Automotive
4.1.2 Machinery
4.1.3 Electronic Appliances
4.1.4 Chemical Building Materials
4.2 Global Polycaprolactam Sales Value by Application
4.2.1 Global Polycaprolactam Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Polycaprolactam Sales Value, by Application (2020-2031)
4.2.3 Global Polycaprolactam Sales Value, by Application (%) (2020-2031)
4.3 Global Polycaprolactam Sales Volume by Application
4.3.1 Global Polycaprolactam Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Polycaprolactam Sales Volume, by Application (2020-2031)
4.3.3 Global Polycaprolactam Sales Volume, by Application (%) (2020-2031)
4.4 Global Polycaprolactam Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Polycaprolactam Sales Value by Region
5.1.1 Global Polycaprolactam Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Polycaprolactam Sales Value by Region (2020-2025)
5.1.3 Global Polycaprolactam Sales Value by Region (2026-2031)
5.1.4 Global Polycaprolactam Sales Value by Region (%), (2020-2031)
5.2 Global Polycaprolactam Sales Volume by Region
5.2.1 Global Polycaprolactam Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Polycaprolactam Sales Volume by Region (2020-2025)
5.2.3 Global Polycaprolactam Sales Volume by Region (2026-2031)
5.2.4 Global Polycaprolactam Sales Volume by Region (%), (2020-2031)
5.3 Global Polycaprolactam Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Polycaprolactam Sales Value, 2020-2031
5.4.2 North America Polycaprolactam Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Polycaprolactam Sales Value, 2020-2031
5.5.2 Europe Polycaprolactam Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Polycaprolactam Sales Value, 2020-2031
5.6.2 Asia Pacific Polycaprolactam Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Polycaprolactam Sales Value, 2020-2031
5.7.2 South America Polycaprolactam Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polycaprolactam Sales Value, 2020-2031
5.8.2 Middle East & Africa Polycaprolactam Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polycaprolactam Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Polycaprolactam Sales Value
6.2.1 Key Countries/Regions Polycaprolactam Sales Value, 2020-2031
6.2.2 Key Countries/Regions Polycaprolactam Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Polycaprolactam Sales Value, 2020-2031
6.3.2 United States Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Polycaprolactam Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Polycaprolactam Sales Value, 2020-2031
6.4.2 Europe Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Polycaprolactam Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Polycaprolactam Sales Value, 2020-2031
6.5.2 China Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.5.3 China Polycaprolactam Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Polycaprolactam Sales Value, 2020-2031
6.6.2 Japan Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Polycaprolactam Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Polycaprolactam Sales Value, 2020-2031
6.7.2 South Korea Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Polycaprolactam Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Polycaprolactam Sales Value, 2020-2031
6.8.2 Southeast Asia Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Polycaprolactam Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Polycaprolactam Sales Value, 2020-2031
6.9.2 India Polycaprolactam Sales Value by Type (%), 2024 VS 2031
6.9.3 India Polycaprolactam Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BASF SE
7.1.1 BASF SE Company Information
7.1.2 BASF SE Introduction and Business Overview
7.1.3 BASF SE Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BASF SE Polycaprolactam Product Offerings
7.1.5 BASF SE Recent Development
7.2 Honeywell
7.2.1 Honeywell Company Information
7.2.2 Honeywell Introduction and Business Overview
7.2.3 Honeywell Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Honeywell Polycaprolactam Product Offerings
7.2.5 Honeywell Recent Development
7.3 Royal DSM N.V
7.3.1 Royal DSM N.V Company Information
7.3.2 Royal DSM N.V Introduction and Business Overview
7.3.3 Royal DSM N.V Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Royal DSM N.V Polycaprolactam Product Offerings
7.3.5 Royal DSM N.V Recent Development
7.4 Lanxess
7.4.1 Lanxess Company Information
7.4.2 Lanxess Introduction and Business Overview
7.4.3 Lanxess Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Lanxess Polycaprolactam Product Offerings
7.4.5 Lanxess Recent Development
7.5 Clariant Corporation
7.5.1 Clariant Corporation Company Information
7.5.2 Clariant Corporation Introduction and Business Overview
7.5.3 Clariant Corporation Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Clariant Corporation Polycaprolactam Product Offerings
7.5.5 Clariant Corporation Recent Development
7.6 Unitika
7.6.1 Unitika Company Information
7.6.2 Unitika Introduction and Business Overview
7.6.3 Unitika Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Unitika Polycaprolactam Product Offerings
7.6.5 Unitika Recent Development
7.7 DOMO Chemicals
7.7.1 DOMO Chemicals Company Information
7.7.2 DOMO Chemicals Introduction and Business Overview
7.7.3 DOMO Chemicals Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 DOMO Chemicals Polycaprolactam Product Offerings
7.7.5 DOMO Chemicals Recent Development
7.8 Firestone Textiles Company
7.8.1 Firestone Textiles Company Company Information
7.8.2 Firestone Textiles Company Introduction and Business Overview
7.8.3 Firestone Textiles Company Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Firestone Textiles Company Polycaprolactam Product Offerings
7.8.5 Firestone Textiles Company Recent Development
7.9 Grupa Azoty
7.9.1 Grupa Azoty Company Information
7.9.2 Grupa Azoty Introduction and Business Overview
7.9.3 Grupa Azoty Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Grupa Azoty Polycaprolactam Product Offerings
7.9.5 Grupa Azoty Recent Development
7.10 LIBOLON
7.10.1 LIBOLON Company Information
7.10.2 LIBOLON Introduction and Business Overview
7.10.3 LIBOLON Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 LIBOLON Polycaprolactam Product Offerings
7.10.5 LIBOLON Recent Development
7.11 Polymeric Resources Corporation
7.11.1 Polymeric Resources Corporation Company Information
7.11.2 Polymeric Resources Corporation Introduction and Business Overview
7.11.3 Polymeric Resources Corporation Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Polymeric Resources Corporation Polycaprolactam Product Offerings
7.11.5 Polymeric Resources Corporation Recent Development
7.12 UBE
7.12.1 UBE Company Information
7.12.2 UBE Introduction and Business Overview
7.12.3 UBE Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 UBE Polycaprolactam Product Offerings
7.12.5 UBE Recent Development
7.13 EMS-Grivory
7.13.1 EMS-Grivory Company Information
7.13.2 EMS-Grivory Introduction and Business Overview
7.13.3 EMS-Grivory Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 EMS-Grivory Polycaprolactam Product Offerings
7.13.5 EMS-Grivory Recent Development
7.14 Shakespeare
7.14.1 Shakespeare Company Information
7.14.2 Shakespeare Introduction and Business Overview
7.14.3 Shakespeare Polycaprolactam Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Shakespeare Polycaprolactam Product Offerings
7.14.5 Shakespeare Recent Development
8 Industry Chain Analysis
8.1 Polycaprolactam Industrial Chain
8.2 Polycaprolactam Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polycaprolactam Sales Model
8.5.2 Sales Channel
8.5.3 Polycaprolactam Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 139
USD 3950.00
(Single User License)
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 142
USD 2900.00
(Single User License)
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 166
USD 4900.00
(Single User License)
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 4250.00
(Single User License)
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-02-24
Pages: 105
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-31
Pages: 103
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-16
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-14
Pages: 139
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-04-27
Pages: 142
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 166
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-02-24
Pages: 105
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-31
Pages: 103
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-16
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now